Immuneresponse to recombinant hepatitis B vaccination in adults

Journal of Communicable Diseases

Volumn 35, Issue 4, 2003, Pages 249-255

  Gandhoke, Inderjeet ^a   Gupta, Sunil ^a   Lal, Shiv ^a   Khare, Shashi ^a  

^a NATIONAL INSTITUTE OF COMMUNICABLE DISEASES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; RECOMBINANT HEPATITIS B VACCINE;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; DOSE RESPONSE; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOGLOBULIN BLOOD LEVEL; INJECTION SITE REACTION; MALE; NORMAL HUMAN; SEROCONVERSION; VACCINATION;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED;

EID: 18144372035     PISSN: 00195138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Tandon BN. Dimensions and issues of HBV control in India. In: Hepatitis B in India; Problems and prevention Eds. Sarin SK and Singhal AK. New Delhi, CBS Publications and Distributors 1996; 1-4.
2. Kane MA. Progress on the control of Hepatitis B infection through immunization. Gut 1993; 34(2): 10-12.
3. World Health Organization. Hepatitis B vaccine - making global progress. EPI Update. October, 1996.
4. West DJ. Scope and design of hepatitis B vaccine clinical trials. Inn: Hepatitis B vaccines in clinical practice (Ed/ Ellis, R. W.), Marcel Dekker, New York. 1993; 159-177.
5. Calandra GB and West DJ. Recommendations for prevention of Hepatitias B with vaccine. In: Hepatitis B vaccines in clinical Practice (Ed. Ellis R. W.), Marcel Dekker, New York 1993; 1-16.
6. Centres for Disease Control. Hepatitis B virus: a comparative strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the immunization Practices Advisory Committee (ACIP) Morbid. Mortal. Wkly Rep 1991; 40(13): 1-25.
7. West DJ, Calandra GB, Hesley TM, Lali V and Miller WJ. Control of Hepatitis B through routine immunization of infants the need for flexible schedules and new combination vaccine formulations. Vaccine 1993; 11(1): 21-24.
8. Mittal SK, Rao S, Sudarshan Kumari, Vyom Aggarwal, Charu Prakash and Thirupuram S. Simultaneous Administration of Hepatitis B vaccine with other E.P.I. Vaccines. Indian J Pediatr 1994; 61: 183-188.
9. Sunil Gomber, Rajesh Sharma, Ramachandran VG, Vibha Talwar and Bharat Singh. Immunogenicity of Hepatitis B Vaccine Incorporated into the Expanded Programme of Immunization Schedule. Indian Pediatrics 2000; 37: 41.
10. Gold Farb J, Medendorp SV, Nagamori K, Buscarino C and Krause D. Comparison study of the immunogenicity and safety of 5 microgram and 10 microgram dosages of recombinant hepatitis B vaccine in healthy children. Pediatr Infect Dis J 1996; 15: 768-771
11. Znang M, Lie K, Ding L and Smego RA. Jr. Duration and efficacy of immune response to Hepatitis B vaccine in high risk chinese adolescents Clin Infect Dis 1993; 16: 165-167.
12. Buchar B, Franciote P, Geudelen B and Fritzell B. Immunogenicity of a recombinant Pre S2 containing Hepatitis B Vaccine vs plasma derived vaccine administered as a booster. Eur J Clin Microbial Inf Dis 1994; 13: 212-217
13. Krugman S and Davidson M. Hepatitis B Vaccine ; Prospects in relation to duration of immunity. Yale J Biol Med 1987; 60: 333-338
14. Jilg W, Schmidt M and Deinhardt F. Vaccination against hepatitis B; Comparison of three different vaccination schedules. Journal of Infectious Diseases 1989; 160: 766-769.
15. West DJ and Calandra GB. Vaccine induced immunological memory for Hepatitis B surface antigen :implications for policy on booster vaccination. Vaccine 1996; 14(11): 1019-1027.